1. Resources
  2. Blogs
  3. How eSignatures Help Clinical Researchers in Being Compliant
How eSignatures are a Practical Tool in Clinical Research

How eSignatures Help Clinical Researchers in Being Compliant

Vijith Menon

Clinical trials need to be conducted by research teams to advance medical research and improve healthcare. The Philippines is a significant player in the global clinical research industry. Trials are necessary to guarantee the safety and quality of food, cosmetics, drugs, and devices.

A meticulous documentation process is also of the essence to gain the green signal from regulatory agencies. In recent years, the clinical research industry in the Philippines has been transitioning towards a paperless model to enhance efficiency and accuracy.

This blog will delve into the documentation process in clinical trials in the Philippines, highlighting the shift toward paperless solutions, discussing the key stakeholders involved in obtaining informed consent in different types of clinical trials, and the impact of implementing eSignatures.

Documentation Process in Clinical Trials in the Philippines

  • Regulatory Approvals and Protocols: The documentation process in the Philippines begins with submitting a comprehensive trial protocol to the Department of Health (DOH) for regulatory approval. This protocol details the study's objectives, methodologies, and ethical considerations, serving as the blueprint for the trial.

  • Informed Consent Forms (ICFs): Informed consent is a requirement in clinical trials, and participants must provide their voluntary and informed consent in writing. Informed Consent Forms (ICFs) are designed to explain the study's purpose, potential risks and benefits, and the rights and responsibilities of participants. These documents must comply with local regulations and guidelines.

  • Ethical Review by Institutional Review Boards (IRBs): Clinical trials in the Philippines require ethical review and approval by Institutional Review Boards (IRBs) associated with the participating institutions. The IRBs evaluate the trial's ethical and scientific aspects, ensuring that the ICF is clear and understandable and that participants' rights and safety are protected.

  • Regulatory Documentation: Once regulatory approval is secured, clinical trial documentation must adhere to the guidelines provided by the FDA or DOH. This documentation encompasses information about the sponsor, trial design, safety measures, and investigator responsibilities.

  • Adverse Event Reporting: Adverse event reporting is critical in the documentation process. Researchers and healthcare professionals are required to document and report on adverse events that occur during the trial to the regulatory authorities, ensuring the safety and well-being of participants.

Transition to a Paperless Model

The clinical research industry in the Philippines, like many other regions, has been embracing digital solutions to streamline documentation processes. The shift towards a paperless model offers several advantages, including:

  • Enhanced Efficiency: Electronic documentation streamlines data capture, storage, and retrieval, reducing the administrative burden associated with paper-based processes.

  • Improved Data Integrity: Digital documentation reduces the risk of errors, ensures data accuracy, and provides real-time access to study information.

  • Simplified Collaboration: Electronic documentation enables seamless communication among stakeholders, both locally and internationally, facilitating remote collaborations and enhancing the efficiency of multi-center trials.

  • Environmental Impact: The transition to a paperless model is environmentally friendly, reducing the consumption of paper and the associated carbon footprint.

Stakeholders in the Consent Process

The number of stakeholders involved in obtaining informed consent may vary depending on the type of clinical trial in the Philippines:

  • Principal Investigator: The principal investigator is responsible for explaining the trial to potential participants, ensuring their comprehension, and obtaining their informed consent. They play a central role in the consent process.

  • Institutional Review Boards (IRBs): IRBs are a crucial part of the consent process. They review and approve the ICF, ensuring it complies with regulatory standards and ethical principles. IRBs also monitor the trial to safeguard participant rights.

  • Sponsor: The sponsor initiates and funds the clinical trial. They are responsible for ensuring that the informed consent process adheres to ethical and regulatory standards, and they may be involved in designing the ICF.

  • Independent Advocates: In certain clinical trials, particularly those involving vulnerable populations, independent advocates may be engaged to represent the best interests of participants and ensure their rights are protected.

  • Regulatory Authorities: Regulatory authorities such as the FDA or DOH are responsible for reviewing the trial documentation, including the informed consent process. They ensure that the trial is conducted in compliance with local regulatory standards and ethical principles.

Don’t Miss to Read: How Electronic Signatures Offer Leverage in Clinical Healthcare.

Importance of Regulatory Compliance in Clinical Healthcare

The practice of clinical healthcare is linked to the principles of transparency, ethics, and adherence to regulatory standards. Clinical trials serve as the bedrock for the development of innovative medical interventions. However, the significance of regulatory compliance extends beyond clinical trials, impacting every aspect of healthcare delivery, from patient care to research.

  • Patient Safety and Quality of Care: Adherence to updated regulations is paramount for ensuring patient safety. Regulations set standards for the training and certification of healthcare professionals, hospital operations, patient rights, and the quality of medical devices and pharmaceuticals. Compliance helps prevent medical errors, ensures appropriate patient care, and reduces the risk of side effects to patients.

  • Ethical Considerations: Regulations are rooted in ethical principles that prioritize the welfare and autonomy of patients. Ethical considerations encompass respect for patient autonomy, beneficence (doing good), non-maleficence (avoiding harm), and justice in allocating healthcare resources.

  • Data Privacy and Security: Healthcare data is increasingly digitized, and the protection of patient information is of paramount importance. Regulations contain strict standards for data privacy and security.

  • Research and Clinical Trials: Adherence to updated regulations is critical for the approval, conduct, and reporting of clinical research. Regulatory bodies, like the DOH, continuously update guidelines to ensure the safety and efficacy of new medical interventions. Non-compliance can result in regulatory sanctions, delays in research, and the invalidation of study results.

  • Legal Consequences of Non-Compliance: Failure to comply with healthcare regulations can have severe legal consequences. Organizations, practitioners, and researchers may face fines, legal action, and the loss of professional licenses. Non-compliance can lead to the closure of healthcare facilities or research programs. Legal ramifications not only harm the individuals or organizations involved but also erode public trust in the healthcare system.

  • Advancements in Medicine: Compliance with regulations can foster innovation by providing a stable and ethical framework for research and development. By adhering to updated rules, researchers and pharmaceutical companies can confidently pursue novel treatments, therapies, and medical devices that improve patient outcomes. Regulatory compliance bolsters public confidence in the safety and efficacy of new medical advancements.

  • Global Health and International Collaboration: Healthcare regulations also have implications for international collaboration and the global health landscape. Compliance with international standards facilitates the sharing of medical knowledge, technologies, and best practices. It enables healthcare professionals and organizations to work together globally, addressing common health challenges and improving healthcare delivery worldwide.

Electronic signatures, or eSignatures, have become a vital component of modern healthcare management, offering a seamless and secure way to automate workflows, streamline approvals, and enhance overall operational efficiency. In the clinical healthcare setting, where patient safety, regulatory compliance, and data security are paramount, eSignatures are pivotal in expediting processes, reducing administrative burdens, and ensuring compliance.

Benefits of eSignatures in Clinical Healthcare

E-signatures offer a digital alternative that mitigates these issues, making it an ideal solution for the healthcare industry. Here are the benefits of its implementation.

  • Workflow Automation: E-signatures streamline and automate various healthcare workflows, from patient admissions and discharges to consent forms, release of medical records, and treatment plans. By integrating eSignatures into electronic health record (EHR) systems and other healthcare software, organizations can reduce manual data entry, eliminate paper documents, and enhance the overall efficiency of healthcare processes.

  • Consent and Authorization Forms: Informed consent is critical in clinical healthcare, especially in clinical trials, surgeries, and medical procedures. Electronic signatures enable patients to review and sign consent forms digitally, expediting the process and providing a clear audit trail. This demonstrates that patients are aware of the risks and benefits of their medical treatments.

  • Regulatory Compliance: Clinical healthcare is subject to numerous regulations. E-signatures can help organizations comply with these regulations by ensuring the security and integrity of electronic patient records and signatures, as well as facilitating access controls and audit trails.

  • Accelerating Approvals: In the healthcare sector, obtaining approvals is often a time-sensitive matter. Whether it's a request for diagnostic tests, prescription refills, or surgical procedures, eSignatures facilitate the rapid review and approval of healthcare orders, reducing delays and improving patient care.

  • Remote Consultations and Telemedicine: The rise of telemedicine has increased the demand for digital signatures. E-signatures allow patients to provide their consent and authorization for telemedicine consultations, prescription refills, and other remote healthcare services quickly and conveniently. This provides patients access to healthcare even when they are unable to visit a physical healthcare facility.

  • Reduction of Errors: By eliminating manual data entry and paper-based processes, eSignatures reduces the likelihood of errors that can occur in healthcare documentation. This enhances the accuracy and integrity of patient records, reducing the potential for medical errors and improving patient safety.

  • Cost Savings: Implementing eSignatures in clinical healthcare can lead to significant cost savings. It reduces the need for paper, printing, storage, and manual processing, reducing operational expenses. Moreover, it optimizes resource allocation, allowing healthcare professionals to focus more on patient care.


The integration of e-signatures into clinical healthcare will usher in a new era of efficiency, compliance, and patient-centric care. These digital signatures play a vital role in automating workflows, accelerating approvals, and reducing administrative burdens. Moreover, eSignatures contribute to patient safety, regulatory compliance, and cost savings, making them an indispensable tool in modern healthcare.

DrySign is an electronic signature provider that reduces the time required to sign clinical trial documents and culminates in reduced operational expenses for clinical research organizations. It paves the way for a paperless process and a digital approach to regulatory compliance.

Create more opportunities by simplifying the contract process using DrySign.

DISCLAIMER: The information on this site is for general information purposes only and is not intended to serve as legal advice. Laws governing the subject matter may change quickly, and Exela cannot guarantee that all the information on this site is current or correct. Should you have specific legal questions about any of the information on this site, you should consult with a licensed attorney in your area.

Contact Us

Subscribe to our blogs

Stay updated with what's happening

Get all our stories delivered straight to your mailbox.
Subscribe to our blog and get the latest stories delivered to you. No spam, no promotional messages. Guaranteed!